A detailed history of New Republic Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, New Republic Capital, LLC holds 2,768 shares of NVS stock, worth $300,051. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,768
Previous 2,491 11.12%
Holding current value
$300,051
Previous $241 Million 22.3%
% of portfolio
0.15%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $25,641 - $29,741
277 Added 11.12%
2,768 $295 Million
Q1 2024

May 07, 2024

BUY
$95.27 - $108.47 $7,049 - $8,026
74 Added 3.06%
2,491 $241 Million
Q4 2023

Feb 12, 2024

BUY
$92.27 - $101.54 $15,870 - $17,464
172 Added 7.66%
2,417 $244 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $3,031 - $3,364
32 Added 1.45%
2,245 $229 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $204,746 - $232,165
2,213 New
2,213 $223 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track New Republic Capital, LLC Portfolio

Follow New Republic Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Republic Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Republic Capital, LLC with notifications on news.